analyst
NA
NASDAQ · NAMS
NewAmsterdam Pharma Company N.V.
Healthcare · Biotechnology
$18.41
Down-$1.10 (-5.64%)
Updated Nov 22, 2026, 2:55 PM
SID Score
3.8/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.1B
- P/E ratio
- -19.49
- Dividend yield
- 0.00%
- 52-week range
- $17.90 – $42.21
- Volume
- 1.75M
- Avg. volume
- 1.15M
Price performance · NAMS
NAMS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 20, 2026
NAMS closed at $18.41 after 20 trading sessions, down 5.73% for the selected period.
- Last close
- $18.41
- Period change
- -5.73%
- Period low
- $18.41
- Period high
- $21.07
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | $19.21 | $19.78 | $18.285 | $18.41 | 1.75M |
| Nov 19, 2026 | $20.00 | $20.36 | $19.30 | $19.51 | 1.98M |
| Nov 18, 2026 | $19.28 | $20.10 | $19.2602 | $19.74 | 1.8M |
| Nov 17, 2026 | $19.45 | $20.2999 | $18.90 | $19.39 | 1.36M |
| Nov 16, 2026 | $19.94 | $20.54 | $19.45 | $19.46 | 1.68M |
| Nov 13, 2026 | $19.93 | $20.62 | $19.48 | $20.14 | 1.67M |
| Nov 12, 2026 | $20.76 | $20.76 | $19.31 | $19.97 | 2.28M |
| Nov 11, 2026 | $19.52 | $20.82 | $19.30 | $20.72 | 2.62M |
| Nov 10, 2026 | $18.97 | $20.04 | $18.90 | $19.18 | 2.36M |
| Nov 9, 2026 | $19.08 | $19.38 | $17.90 | $19.00 | 2.76M |
| Nov 6, 2026 | $19.10 | $19.385 | $18.50 | $18.90 | 1.71M |
| Nov 5, 2026 | $20.77 | $20.77 | $18.86 | $18.89 | 1.56M |
| Nov 4, 2026 | $22.26 | $22.26 | $19.81 | $20.93 | 1.89M |
| Nov 3, 2026 | $19.74 | $20.46 | $19.59 | $19.90 | 2.07M |
| Nov 2, 2026 | $20.23 | $20.955 | $19.545 | $19.56 | 2.01M |
| Oct 30, 2026 | $20.60 | $20.94 | $19.78 | $20.06 | 1.14M |
| Oct 29, 2026 | $21.45 | $21.725 | $20.55 | $20.76 | 1.03M |
| Oct 28, 2026 | $20.59 | $21.115 | $20.09 | $21.07 | 1.45M |
| Oct 27, 2026 | $19.50 | $20.60 | $19.32 | $20.50 | 1.97M |
| Oct 26, 2026 | $19.68 | $19.98 | $19.265 | $19.53 | 1.56M |
Latest NAMS news
The latest Smart Investors Daily articles mentioning NAMS.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…

